Abstract:Repeated exposure to antibiotics and changes in the diet and environment shift the gut microbial diversity and composition, making the host susceptible to pathogenic infection. The emergence and ongoing spread of AMR pathogens is a challenging public health issue. Recent evidence showed that probiotics and prebiotics may play a role in decolonizing drug-resistant pathogens by enhancing the colonization resistance in the gut. This review aims to analyze available evidence from human-controlled trials to determine the effect size of probiotic interventions in decolonizing AMR pathogenic bacteria from the gut. We further studied the effects of prebiotics in human and animal studies. PubMed, Embase, Web of Science, Scopus, and CINAHL were used to collect articles. The random-effects model meta-analysis was used to pool the data. GRADE Pro and Cochrane collaboration tools were used to assess the bias and quality of evidence. Out of 1395 citations, 29 RCTs were eligible, involving 2871 subjects who underwent either probiotics or placebo treatment to decolonize AMR pathogens. The persistence of pathogenic bacteria after treatment was 22%(probiotics) and 30.8%(placebo). The pooled odds ratio was 0.59(95% CI:0.43–0.81), favoring probiotics with moderate certainty ( p = 0.0001) and low heterogeneity ( I 2 = 49.2%, p = 0.0001). The funnel plot showed no asymmetry in the study distribution (Kendall'sTau = −1.06, p = 0.445). In subgroup, C. difficile showed the highest decolonization (82.4%) in probiotics group. Lactobacillus -based probiotics and Saccharomyces boulardii decolonize 71% and 77% of pathogens effectively. The types of probiotics ( p < 0.018) and pathogens ( p < 0.02) significantly moderate the outcome of decolonization, whereas the dosages and regions of the studies were insignificant ( p < 0.05). Prebiotics reduced the pathogens from 30% to 80% of initial challenges. Moderate certainty of evidence suggests that probiotics and prebiotics may decolonize pathogens through modulation of gut diversity. However, more clinical outcomes are required on particular strains to confirm the decolonization of the pathogens. Protocol registration: PROSPERO (ID = CRD42021276045).

Can probiotics trigger a paradigm shift for cleaning healthcare environments? A narrative review

Comparative analysis of surface sanitization protocols on the bacterial community structures in the hospital environment

Tackling transmission of infectious diseases: A probiotic‐based system as a remedy for the spread of pathogenic and resistant microbes

A critical assessment of microbial-based antimicrobial sanitizing of inanimate surfaces in healthcare settings

Using probiotics in clinical practice: Where are we now? A review of existing meta-analyses

Hard Surface Biocontrol in Hospitals Using Microbial-Based Cleaning Products

Disinfectant, Soap or Probiotic Cleaning? Surface Microbiome Diversity and Biofilm Competitive Exclusion

The role of the healthcare environment in the spread of multidrug-resistant organisms: update on current best practices for containment

Cleaning and disinfecting surfaces in hospitals and long-term care facilities for reducing hospital and facility-acquired bacterial and viral infections: A systematic review

Exploring the Probiotic Potential of Bacteroides spp. Within One Health Paradigm

The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomes

Beyond probiotics: a narrative review on an era of revolution

Probiotics: insights and new opportunities for Clostridioides difficile intervention

Probiotics in Health Care: A Critical Appraisal

Viewpoint: The impending pandemic of resistant organisms - a paradigm shift towards source control is needed

The role of environmental cleaning in the control of hospital-acquired infection

Probiotic approach to pathogen control in premise plumbing systems? A review

Innovative Methods of Hospital Disinfection in Prevention of Healthcare-Associated Infections

Metagenomic insights into microbial contamination in critical healthcare environments and the efficacy of a novel "HLE" disinfectant

Environmental contamination makes an important contribution to hospital infection

Bacillus-based probiotic cleansers reduce the formation of dry biofilms on common hospital surfaces